Factors Associated with the Outcomes of Patients with Hospital-Acquired Pneumonia (HAP) at Dr. Moewardi General Hospital, Surakarta
Downloads
Introduction: Hospital-acquired pneumonia (HAP) is a common infection with a poor prognosis. Previous studies on factors influencing HAP outcomes have yielded inconsistent findings. Therefore, further research is needed to determine risk factors that affect HAP outcomes. This study evaluated the factors associated with HAP outcomes to enable timely interventions to reduce mortality, costs, and length of stay (LOS).
Methods: This cross-sectional study was conducted at Dr. Moewardi General Hospital, Surakarta, using medical record data from January to December 2022. The data included age, gender, malnutrition, anemia, level of consciousness, comorbidities, bacterial culture, and multidrug-resistant organisms (MDROs). The analyses were performed using the Chi-squared and Mann-Whitney U tests, followed by multiple logistic and linear regression tests to determine the correlation between risk factors and outcomes (recovery, death, and LOS).
Results: This study included 102 patients with HAP, the majority being males (64.7%) aged 60 years old and above. Additionally, most patients did not exhibit malnutrition (87.3%) or anemia (96.1%), had normal levels of consciousness (67.6%) and mild comorbidities (60.8%), were not infected with MDROs (66.7%), and were predominantly infected by Klebsiella pneumoniae (21.6%). The multiple logistic regression test revealed that decreased consciousness was significantly associated with increased mortality (p < 0.001). Meanwhile, age 60 years old and above was significantly associated with a shorter LOS (p = 0.05).
Conclusion: The majority of HAP cases occurred in men aged 60 years and above. Furthermore, there was a significant relationship between decreased consciousness and increased mortality, as well as between the age of 60 years and above and a shorter LOS.
Perhimpunan Dokter Paru Indonesia (PDPI). Panduan Umum Praktik Klinis Penyakit Paru dan Pernapasan. Jakarta: Perhimpunan Dokter Paru Indonesia (PDPI), https://bukupdpi.klikpdpi.com/wp-content/uploads/2022/08/BUKU-PUPK-PDPI-2021.pdf (2021).
Kim BG, Kang M, Lim J, et al. Comprehensive Risk Assessment for Hospital-Acquired Pneumonia: Sociodemographic, Clinical, and Hospital Environmental Factors Associated with the Incidence of Hospital-Acquired Pneumonia. BMC Pulm Med 2022; 22: 21. [PubMed]
Shebl E, Gulick PG. Nosocomial Pneumonia, https://www.ncbi.nlm.nih.gov/books/NBK535441/ (2022).
Dongol S, Kayastha G, Maharjan N, et al. Epidemiology, Etiology, and Diagnosis of Health Care Acquired Pneumonia Including Ventilator-Associated Pneumonia in Nepal. PLoS One 2021; 16: e0259634. [PloS One]
Zaragoza R, Vidal-Cortés P, Aguilar G, et al. Update of the Treatment of Nosocomial Pneumonia in the ICU. Crit Care 2020; 24: 383. [PubMed]
Hyun H, Song JY, Yoon JG, et al. Risk Factor-Based Analysis of Community-Acquired Pneumonia, Healthcare-Associated Pneumonia and Hospital-Acquired Pneumonia: Microbiological Distribution, Antibiotic Resistance, and Clinical Outcomes. PLoS One 2022; 17: e0270261. [PloS One]
Gonçalves-Pereira J, Mergulhão P, Nunes B, et al. Incidence and Impact of Hospital-Acquired Pneumonia: A Portuguese Nationwide Four-Year Study. J Hosp Infect 2021; 112: 1–5. [PubMed]
Ko RE, Min KH, Hong SB, et al. Characteristics, Management, and Clinical Outcomes of Patients with Hospital-Acquired and Ventilator-Associated Pneumonia: A Multicenter Cohort Study in Korea. Tuberc Respir Dis (Seoul) 2021; 84: 317–325. [PubMed]
Patty CM, Sandidge-Renteria A, Orique S, et al. Incidence and Predictors of Nonventilator Hospital-Acquired Pneumonia in a Community Hospital. J Nurs Care Qual 2021; 36: 74–78. [PubMed]
Jiao J, Yang XY, Li Z, et al. Incidence and Related Factors for Hospital-Acquired Pneumonia Among Older Bedridden Patients in China: A Hospital-Based Multicenter Registry Data Based Study. Front Public Heal 2019; 7: 221. [PubMed]
Peng J, Zhu G, Xiao S, et al. Elevated Homocysteine Levels Predict Hospital-Acquired Pneumonia and Poor Functional Outcomes in Primary Intracerebral Hemorrhage. Front Neurol; 13, https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2022.926963 (2022).
Wakabayashi T, Iwata H. Outcome, Diagnosis, and Microbiological Profile Comparison of Community- and Hospital-Acquired Bacteremia: A Retrospective Cohort Study. J Gen Fam Med 2021; 22: 327–333. [PubMed]
Kumar RG, Kesinger MR, Juengst SB, et al. Effects of Hospital-Acquired Pneumonia on Long-Term Recovery and Hospital Resource Utilization Following Moderate to Severe Traumatic Brain Injury. J Trauma Acute Care Surg 2020; 88. [PubMed]
Quinn B, Giuliano KK, Baker D. Non-Ventilator Health Care-Associated Pneumonia (NV-HAP): Best Practices for Prevention of NV-HAP. Am J Infect Control 2020; 48: A23–A27. [PubMed]
Qi W, Murphy TE, Doyle MM, et al. Association between Daily Average of Mobility Achieved During Physical Therapy Sessions and Hospital-Acquired or Ventilator-Associated Pneumonia among Critically Ill Patients. J Intensive Care Med 2022; 38: 418–424. [PubMed]
Naito Y, Kamiya M, Morishima N, et al. Association between Out-of-Bed Mobilization and Complications of Immobility in Acute Phase of Severe Stroke: A Retrospective Observational Study. J Stroke Cerebrovasc Dis 2020; 29: 105112. [PubMed]
Guo T, Dou L, Zhou X. Risk Factors of Stroke Complicated with Hospital-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Cohort Studies. Ann Palliat Med 2021; 10: 12381–12389. [PubMed]
Zilberberg MD, Nathanson BH, Puzniak LA, et al. Descriptive Epidemiology and Outcomes of Nonventilated Hospital-Acquired, Ventilated Hospital-Acquired, and Ventilator-Associated Bacterial Pneumonia in the United States, 2012-2019. Crit Care Med 2022; 50: 460–468. [PubMed]
Feng DY, Zhou YQ, Zou XL, et al. Factors Influencing Mortality in Hospital-Acquired Pneumonia Caused by Gram-Negative Bacteria in China. J Infect Public Health 2019; 12: 630–633. [PubMed]
López-de-Andrés A, Albaladejo-Vicente R, de Miguel-Diez J, et al. Gender Differences in Incidence and In-Hospital Outcomes of Community-Acquired, Ventilator-Associated and Nonventilator Hospital-Acquired Pneumonia in Spain. Int J Clin Pract 2021; 75: e13762. [PubMed]
Koerber MK, Agaoglu S, Bichmann A, et al. Female Patients with Pneumonia on Intensive Care Unit are under Risk of Fatal Outcome. Medicina (B Aires); 58. Epub ahead of print 2022. [PubMed]
Warda AEA, Sarhan RM, Al-Fishawy HS, et al. Continuous versus Intermittent Linezolid Infusion for Critically Ill Patients with Hospital-Acquired and Ventilator-Associated Pneumonia: Efficacy and Safety Challenges. Pharmaceuticals; 15. Epub ahead of print 2022. [PubMed]
Polovina M, Tomić M, Viduljević M, et al. Predictors and Prognostic Implications of Hospital-Acquired Pneumonia in Patients Admitted for Acute Heart Failure. Frontiers in Cardiovascular Medicine; 10, https://www.frontiersin.org/articles/10.3389/fcvm.2023.1254306 (2023).
Elsener C, Beeler PE, Battegay E, et al. Risk Factors of In-Hospital Mortality in Patients Treated for Pneumonia at a Tertiary Care Centre in Switzerland. Respiration 2020; 99: 637–645. [PubMed]
Han J, Lv Z, Shen M, et al. Risk Factors for Hospital-Acquired Pneumonia among Inpatients with Mental Disorders in a Large Mental Health Center within a Tertiary General Hospital. Am J Infect Control 2023; 51: 446–453. [PubMed]
Jang JH, Kim T, Yeo HJ, et al. Impact of Nutrition and Physical Activity on Outcomes of Hospital-Acquired Pneumonia. Sci Rep 2022; 12: 15605. [PubMed]
Paskah M, Manik L, Asdie RH, et al. Evaluation of Empirical Antibiotic Usage and Cost Analysis of Patients with Nosocomial Pneumonia in ICU of Dr. Sardjito General Hospital, Yogyakarta. 2020; 1: 79–88. [Journal]
Jiao J, Li Z, Wu X, et al. Risk Factors for 3-Month Mortality in Bedridden Patients with Hospital-Acquired Pneumonia: A Multicentre Prospective Study. PLoS One 2021; 16: e0249198. [PloS One]
de Miguel-Yanes JM, Lopez-de-Andres A, Jiménez-Garcia R, et al. Incidence, Outcomes and Sex-Related Disparities in Pneumonia: A Matched-Pair Analysis with Data from Spanish Hospitals (2016-2019). J Clin Med 2021; 10: 4339. [PubMed]
Costa RD, Baptista JP, Freitas R, et al. Hospital-Acquired Pneumonia in a Multipurpose Intensive Care Unit: One-Year Prospective Study. Acta Med Port 2019; 32: 746–753. [PubMed]
Peters L, Olson L, Khu DTK, et al. Multiple Antibiotic Resistance as a Risk Factor for Mortality and Prolonged Hospital Stay: A Cohort Study among Neonatal Intensive Care Patients with Hospital-Acquired Infections Caused by Gram-Negative Bacteria in Vietnam. PLoS One 2019; 14: e0215666. [PloS One]
Poovieng J, Sakboonyarat B, Nasomsong W. Bacterial Etiology and Mortality Rate in Community-Acquired Pneumonia, Healthcare-Associated Pneumonia and Hospital-Acquired Pneumonia in Thai University Hospital. Sci Rep 2022; 12: 9004. [PubMed]
Nirwati H, Sinanjung K, Fahrunissa F, et al. Biofilm Formation and Antibiotic Resistance of Klebsiella pneumoniae Isolated from Clinical Samples in a Tertiary Care Hospital, Klaten, Indonesia. BMC Proc 2019; 13: 20. [PubMed]
Sharma A, Thakur A, Thakur N, et al. Changing Trend in the Antibiotic Resistance Pattern of Klebsiella pneumonia Isolated from Endotracheal Aspirate Samples of ICU Patients of a Tertiary Care Hospital in North India. Cureus 2023; 15: e36317.
Kot B, Piechota M, Szweda P, et al. Virulence Analysis and Antibiotic Resistance of Klebsiella pneumoniae Isolates from Hospitalised Patients in Poland. Sci Rep 2023; 13: 4448. [Journal]
Wang G, Zhao G, Chao X, et al. The Characteristic of Virulence, Biofilm and Antibiotic Resistance of Klebsiella pneumoniae. Int J Environ Res Public Health; 17. Epub ahead of print August 2020. [PubMed]
Kyriakidis I, Vasileiou E, Pana ZD, et al. Acinetobacter baumannii Antibiotic Resistance Mechanisms. Pathog (Basel, Switzerland); 10. Epub ahead of print March 2021. [PubMed]
Motbainor H, Bereded F, Mulu W. Multi-Drug Resistance of Blood Stream, Urinary Tract and Surgical Site Nosocomial Infections of Acinetobacter baumannii and Pseudomonas aeruginosa among Patients Hospitalized at Felegehiwot Referral Hospital, Northwest Ethiopia: A Cross-Sectional Study. BMC Infect Dis 2020; 20: 92. [PubMed]
Solmaz İ, Kalın BS. Assessment of Antibiotic Resistance of Infectious Agents in Patients with Pneumonia in Tertiary Critical Care Unit and Effect on Clinical Outcomes. Int J Clin Pract 2021; 75: e13872. [PubMed]
Li F, Zhu J, Hang Y, et al. Clinical Characteristics and Prognosis of Hospital-Acquired Klebsiella pneumoniae Bacteremic Pneumonia versus Escherichia coli Bacteremic Pneumonia: A Retrospective Comparative Study. Infect Drug Resist 2023; 16: 4977–4994. [PubMed]
Copyright (c) 2024 Natasha Nawanindha, Leli Saptawati, Vitri Widyaningsih
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.
JR (